CPhI 2017: Centroflora CMS nominated for the 2017 CPhI Pharma Award for Corporate Social Responsibility
Luxembourg, September 20, 2017 –
CPhI Award nomination is for the company’s “Partnership for a Better World” project
Centroflora CMS has again been nominated for the CPhI Award in the category “Excellence in Pharma: Corporate Social Responsibility” for the project “Partnership for a Better World”. This is the second year in succession that the company has been in the running for the Award.
Centroflora CMS is the key financial sponsor of the “Partnership for a Better World” program that supports thousands of families in Brazil involved in the wild harvesting of native plants used for the manufacturing of pharmaceutical APIs (active pharmaceutical ingredients) such as pilocarpine. Created in 2003, the core principles of the program are to actively incorporate and promote ethical trade and sustainability concepts into the harvesting process.
The “Partnership for a Better World” program has brought meaningful and tangible benefits to thousands of disadvantaged families during its 14 years of existence, while at the same time improving the eco-system around various plants. It is a demonstration that economics and environmental stewardship can go hand-in-hand when all parties involved in the supply chain of an API are willing to contribute.
In 2015 Centroflora CMS won the CPhI Pharma Award for Excellence in Partnering & Outsourcing for its work around the takeover of the phytochemical portfolio of APIs from Boehringer Ingelheim.